【Chifeng Pharmaceutical】 KXT-II-300 Flexible vibration isolation throat Contract
The official website of Shanghai Songjiang introduces to you: 【Chifeng Pharmaceutical】 KXT-II-300 Flexible vibration isolation throat Contract information. Songjiang Group provides high-quality flexible vibration isolation throat products to numerous pharmaceutical factories. The durable quality saves owners the cost of repeated maintenance and replacement, thus reducing their expenses.
1.Introduction to Chifeng Pharmaceutical:
Chifeng Pharmaceutical Co., Ltd. (formerly Chifeng Pharmaceutical Factory) was founded in June 1949. It is the first pharmaceutical enterprise established in the Inner Mongolia Autonomous Region and the largest ephedrine producer in the country. After 60 years of development, Chifeng Pharmaceutical has evolved from a small manual workshop in the early days of its establishment into a large comprehensive pharmaceutical enterprise today. It integrates scientific research and development, antibiotics, nutritional medicines, and energy production, with a focus on biotechnology and pharmaceutical and nutritional product materials. Throughout its 60-year development, Chifeng Pharmaceutical has undergone several reform and restructuring phases. In 2001, Chifeng Pharmaceutical Factory and Chifeng Northern United Pharmaceutical Factory underwent “debt-to-equity” conversion, reorganizing with China Huarong Corporation to become Chifeng Pharmaceutical (Group) Co., Ltd. In the same year, an investment of over 11 million RMB led to the establishment of Chifeng Keyuan Investment Development Co., Ltd. In collaboration with investors from Hainan, Shenzhen, and other regions, Chifeng Aike Pharmaceutical Technology Co., Ltd. was jointly established. In November of the same year, the formulation plant was reorganized to establish Chifeng Mengxin Pharmaceutical Co., Ltd. In 2003, Chifeng Pharmaceutical joined forces with Shanghai Industry for a strong alliance. Shanghai invested over 70 million RMB in the production of Aike and Mengxin companies. In 2008, Chifeng Pharmaceutical cooperated with Shanghai Desano Pharmaceuticals Development Co., Ltd. to establish Chifeng Pharmaceutical Co., Ltd. In 2008, the company achieved sales revenue of 332 million RMB, profits before tax of 19 million RMB, and exported goods worth 24 million USD.
Chifeng Pharmaceutical Co., Ltd. Chairman Zhao Jianmin stated that Chifeng Pharmaceutical is at a crucial point of transformation and a second entrepreneurial venture. In the next step, they will motivate themselves with the spirit of “hard work, entrepreneurship, and service to the country.” In 2010, the company plans to add 2-3 new products of a certain economic scale on the basis of existing pharmaceutical ingredients, expand new pharmaceutical raw material and formulation production bases, achieve an overall sales revenue of over 1 billion RMB, pre-tax profits of over 200 million RMB, and a significant increase in employee income. At the same time, they aim to build the company into a comprehensive pharmaceutical group with annual sales of 3-5 billion RMB, synchronous development of pharmaceutical ingredients and formulations, and a competitive advantage in both the global and regional markets through 10 years of development.
Chifeng Pharmaceutical Co., Ltd. is a joint-stock company established through asset restructuring by Chifeng Pharmaceutical Group and Shanghai Desano Company. The company has taken over all the assets, liabilities, personnel, and business operations of Chifeng Pharmaceutical Group, serving as a new platform for the production, operation, and industrial development of Chifeng Pharmaceutical.
Building upon nearly 60 years of historical development of Chifeng Pharmaceutical Group, Chifeng Pharmaceutical Co., Ltd. has formed a product category mainly consisting of the Tetracycline series, Griseofulvin, and large-capacity injections. All products have obtained GMP certification, with the Tetracycline series and Griseofulvin also certified by the U.S. FDA and holding the European COS certificate. The company is recognized as a high-tech enterprise in the Inner Mongolia Autonomous Region.
2. The following is a scanned copy of the contract signed between Shanghai Songjiang and Chifeng Pharmaceutical Co., Ltd. This contract serves only as proof of collaboration between the two parties. Please do not reproduce or modify. Thank you for your cooperation.
The official website of Shanghai Songjiang presents to you: Contract Information for Chifeng Pharmaceutical Co., Ltd.’s KXT-II-300 Flexible vibration isolation throat, including related products such as Single Sphere Rubber Joints. Songjiang Group’s flexible vibration isolation throat rubber joints, including single sphere rubber joints, are widely used in the pharmaceutical industry across the country. The above case represents an example of Songjiang Group providing contract support for Chifeng Pharmaceutical Co., Ltd.’s KXT-II-300 Flexible vibration isolation throat.
If you wish to learn more about pharmaceutical cases, please click: Songjiang Group Pharmaceutical Case Information. Disclaimer: Our factory has no branches across the country, strictly preventing counterfeiting. Factory Address: Songjiang Group, Shuangdian Industrial Zone, Nantong City.
